当前位置: X-MOL 学术Org. Process Res. Dev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Development of a Scalable Alkylation via a Protection/Deprotection Sequence for BMT-773752: Key Intermediate in the Synthetic Route to Repotrectinib
Organic Process Research & Development ( IF 3.1 ) Pub Date : 2024-05-08 , DOI: 10.1021/acs.oprd.4c00061
Han Zhang 1 , Binfeng Li 2 , Jin Yang 2 , Changchun Xu 2 , Rafaela Carmona 1 , Jason Zhu 1 , Bilal Hoblos 1 , Steven Wisniewski 1
Affiliation  

The development of a practical and scalable synthetic route to BMT-773752-02, a key starting material for repotrectinib, is described. The original sequence exhibited various limitations such as use of pyrophoric organolithium reagents, low yield, poor diastereoselectivity, and lengthy workup/purification procedures, which were overcome by development of a new route. A salt screening was conducted to improve the physical properties of the title compound. The scalability of the newly designed synthetic strategy has been demonstrated on multihundred-kilogram scale production to afford greater than a metric ton of this intermediate.

中文翻译:

通过 BMT-773752 的保护/去保护序列开发可扩展的烷基化:Repotrectinib 合成路线中的关键中间体

描述了 BMT-773752-02(repotrectinib 的关键起始材料)的实用且可扩展的合成路线的开发。原始序列表现出各种局限性,例如使用自燃有机锂试剂、产量低、非对映选择性差以及冗长的后处理/纯化程序,但通过开发新路线克服了这些局限性。进行盐筛选以改善标题化合物的物理性质。新设计的合成策略的可扩展性已在数百公斤规模的生产中得到证明,可以提供超过一吨的这种中间体。
更新日期:2024-05-09
down
wechat
bug